Mora-Bitria L, Asquith B
    
    
    Front Immunol. 2024; 15:1477991.
  
  
    PMID: 39559364
    
          PMC: 11570266.
    
          DOI: 10.3389/fimmu.2024.1477991.
      
 
                                  
  
    Dzanibe S, Wilk A, Canny S, Ranganath T, Alinde B, Rubelt F
    
    
    Nat Commun. 2024; 15(1):4080.
  
  
    PMID: 38744812
    
          PMC: 11093981.
    
          DOI: 10.1038/s41467-024-47955-5.
      
 
                                  
  
    Schramm C, Moon D, Peyton L, Lima N, Wake C, Boswell K
    
    
    Nat Commun. 2023; 14(1):7961.
  
  
    PMID: 38042809
    
          PMC: 10693617.
    
          DOI: 10.1038/s41467-023-43420-x.
      
 
                                  
  
    Palupi S, Pambudi I, Surya A, Bramanthi R, Arfi M, Suyanto S
    
    
    Cureus. 2023; 15(10):e46353.
  
  
    PMID: 37790868
    
          PMC: 10544859.
    
          DOI: 10.7759/cureus.46353.
      
 
                                  
  
    Pinder C, Jankovic D, Fox T, Kirkwood A, Enfield L, Alrubayyi A
    
    
    Br J Haematol. 2023; 202(6):1091-1103.
  
  
    PMID: 37402627
    
          PMC: 10953351.
    
          DOI: 10.1111/bjh.18962.
      
 
                              
              
                              
                                      
  Disrupted memory T cell expansion in HIV-exposed uninfected infants is preceded by premature skewing of T cell receptor clonality.
  
    Dzanibe S, Wilk A, Canny S, Ranganath T, Alinde B, Rubelt F
    
    
    bioRxiv. 2023; .
  
  
    PMID: 37292866
    
          PMC: 10245741.
    
          DOI: 10.1101/2023.05.19.540713.
      
 
                                          
                                                          
  Natural killer cells- from innate cells to the discovery of adaptability.
  
    Basilio-Queiros D, Mischak-Weissinger E
    
    
    Front Immunol. 2023; 14:1172437.
  
  
    PMID: 37275911
    
          PMC: 10232812.
    
          DOI: 10.3389/fimmu.2023.1172437.
      
 
                                          
                                                          
  Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain.
  
    Takano T, Sato T, Kotaki R, Moriyama S, Fukushi S, Shinoda M
    
    
    Nat Commun. 2023; 14(1):1451.
  
  
    PMID: 36922492
    
          PMC: 10016167.
    
          DOI: 10.1038/s41467-023-37128-1.
      
 
                                          
                                                          
  NK Cells in Protection from HIV Infection.
  
    Bernard N, Alsulami K, Pavey E, Dupuy F
    
    
    Viruses. 2022; 14(6).
  
  
    PMID: 35746615
    
          PMC: 9231282.
    
          DOI: 10.3390/v14061143.
      
 
                                          
                                                          
  Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.
  
    Bernard N, Kant S, Kiani Z, Tremblay C, Dupuy F
    
    
    Front Immunol. 2022; 13:879124.
  
  
    PMID: 35720328
    
          PMC: 9205404.
    
          DOI: 10.3389/fimmu.2022.879124.
      
 
                                          
                                                          
  Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.
  
    Takano T, Morikawa M, Adachi Y, Kabasawa K, Sax N, Moriyama S
    
    
    Cell Rep Med. 2022; 3(5):100631.
  
  
    PMID: 35545084
    
          PMC: 9023335.
    
          DOI: 10.1016/j.xcrm.2022.100631.
      
 
                                          
                                                          
  Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
  
    Shen C, Yen C, Fu Y, Cheng C, Shen T, Chang P
    
    
    Front Immunol. 2022; 13:807454.
  
  
    PMID: 35145520
    
          PMC: 8822242.
    
          DOI: 10.3389/fimmu.2022.807454.
      
 
                                          
                                                          
  NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
  
    Cuapio A, Boulouis C, Filipovic I, Wullimann D, Kammann T, Parrot T
    
    
    Mol Med. 2022; 28(1):20.
  
  
    PMID: 35135470
    
          PMC: 8822735.
    
          DOI: 10.1186/s10020-022-00443-2.
      
 
                                          
                                                          
  Targeting natural killer cells to enhance vaccine responses.
  
    Cox A, Cevik H, Feldman H, Canaday L, Lakes N, Waggoner S
    
    
    Trends Pharmacol Sci. 2021; 42(9):789-801.
  
  
    PMID: 34311992
    
          PMC: 8364504.
    
          DOI: 10.1016/j.tips.2021.06.004.
      
 
                                          
                                                          
  Phenotypic and Functional Characteristics of a Novel Influenza Virus Hemagglutinin-Specific Memory NK Cell.
  
    Zheng J, Wen L, Yen H, Liu M, Liu Y, Teng O
    
    
    J Virol. 2021; 95(12).
  
  
    PMID: 33827945
    
          PMC: 8316001.
    
          DOI: 10.1128/JVI.00165-21.
      
 
                                          
                                                          
  Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation.
  
    Ragunathan K, Upfold N, Oksenych V
    
    
    Int J Mol Sci. 2020; 21(22).
  
  
    PMID: 33207781
    
          PMC: 7696681.
    
          DOI: 10.3390/ijms21228635.
      
 
                                          
                                                          
  -Deficient Mice Exhibit Cytokine-Related Transcriptomic Signatures.
  
    Li D, Bradley T, Cain D, Pedroza-Pacheco I, Aggelakopoulou M, Parks R
    
    
    Immunohorizons. 2020; 4(11):713-728.
  
  
    PMID: 33172842
    
          PMC: 8050958.
    
          DOI: 10.4049/immunohorizons.2000088.
      
 
                                          
                                                          
  Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
  
    Pierce S, Geanes E, Bradley T
    
    
    Front Cell Infect Microbiol. 2020; 10:231.
  
  
    PMID: 32509600
    
          PMC: 7248265.
    
          DOI: 10.3389/fcimb.2020.00231.
      
 
                                          
                                                          
  Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection.
  
    Borst K, Flindt S, Blank P, Larsen P, Chhatbar C, Skerra J
    
    
    PLoS Pathog. 2020; 16(2):e1008279.
  
  
    PMID: 32023327
    
          PMC: 7028289.
    
          DOI: 10.1371/journal.ppat.1008279.
      
 
                                          
                                                          
  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.
  
    Gyurova I, Ali A, Waggoner S
    
    
    Viral Immunol. 2019; 33(4):334-341.
  
  
    PMID: 31800366
    
          PMC: 7247022.
    
          DOI: 10.1089/vim.2019.0129.